Hyblate Medical · raw details

Hybrid Catheter to Treat Atrial Fibrillation · Founded 2018

inactive Pre-Seed ← back to profile

About

Hybrid Catheter to Treat Atrial Fibrillation

Hyblate Medical developed the Hyblate catheter to treat atrial fibrillation (irregular heartbeat). Hyblate offers a safe and effective treatment for atrial fibrillation by combining the advantages of two current ablation methods into a hybrid catheter with effective control mechanisms.

Identity

NameHyblate Medical
Slughyblate-medical
Type / kindstartup
Source _idagxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoLXDoMwKDA

Status

Statusinactive
Status reasonNon Active, Feb 2023 ceased to operate
Last update2026-05-17

Location

HQ country codeIL
HQ addressMisgav, Israel

Web & social

LinkedInhttps://www.linkedin.com/company/33256500

Classifications

Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
medical-devicestreatmentsheart-diseasescatheterscardiologymedical-technologies

Funding

Total raised—
Current stagePre-Seed

Raw source document

Show full JSON (0 KB) 
{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}